Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 143

    Merck wins USFDA approval for Keytruda as combo therapy for kidney cancer

    Merck wins USFDA approval for Keytruda as combo therapy for kidney cancer

    Farhat Nasim22 April 2019 9:30 AM IST
    New Delhi: Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (USFDA) has approved...
    Measles Outbreak: Judge refuses to lift NYCs mandatory vaccination order

    Measles Outbreak: Judge refuses to lift NYCs mandatory vaccination order

    Medical Dialogues Bureau22 April 2019 9:00 AM IST
    In a six-page decision rendered hours after a hearing on the matter, Judge Lawrence Knipel denied the parents’ petition seeking to lift the...
    Novotech partners with major hospitals to strengthen South Korean clinical capabilities

    Novotech partners with major hospitals to strengthen South Korean clinical capabilities

    Garima22 April 2019 9:00 AM IST
    Novotech CEO Dr John Moller said increasingly biotech clients were running their Phase I studies in Australia and benefiting from the 41% R&D tax...
    USFDA permits marketing of first medical device for treatment of ADHD

    USFDA permits marketing of first medical device for treatment of ADHD

    Medical Dialogues Bureau21 April 2019 10:26 AM IST
    The U.S. Food and Drug Administration permitted marketing of the first medical device to treat attention deficit hyperactivity disorder (ADHD). The...
    Merck Foundation defines interventions to break infertility stigma at IFFS World Congress

    Merck Foundation defines interventions to break infertility stigma at IFFS World Congress

    Farhat Nasim21 April 2019 9:30 AM IST
    Minister of Health, Republic of The Gambia said together with Merck Foundation, we want to remove the stigma associated with it by creating a cultural...
    USFDA nod to Teva generic nasal spray-Narcan to treat opioid overdose

    USFDA nod to Teva generic nasal spray-Narcan to treat opioid overdose

    Medical Dialogues Bureau21 April 2019 9:27 AM IST
    The U.S. Food and Drug Administration granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a...
    AMO Pharma launches clinician-completed rating scale for congenital myotonic dystrophy type 1

    AMO Pharma launches clinician-completed rating scale for congenital myotonic dystrophy type 1

    Farhat Nasim21 April 2019 9:15 AM IST
    LONDON: AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood-onset neurogenetic disorders with...
    Thermo Fisher, NX Prenatal collaborates to advance noninvasive risk assessments of pregnancy outcomes

    Thermo Fisher, NX Prenatal collaborates to advance noninvasive risk assessments of pregnancy outcomes

    Garima21 April 2019 8:59 AM IST
    Collaboration with NX Prenatal is aiming to enable Thermo Fisher to better evaluate maternal and fetal biomarkers during pregnancy that correlate with...
    Second death in Novartis gene therapy trials under investigation

    Second death in Novartis gene therapy trials under investigation

    Medical Dialogues Bureau20 April 2019 12:29 PM IST
    Novartis AG, which this week announced positive interim trial results for its experimental gene therapy for spinal muscular atrophy, on Friday said...
    Lower dose of Pfizer, Eli Lilly blockbuster painkiller tanezumab misses target in late stage study

    Lower dose of Pfizer, Eli Lilly blockbuster painkiller tanezumab misses target in late stage study

    Farhat Nasim20 April 2019 10:00 AM IST
    The drug, tanezumab, belongs to a new category of pain medications that target nerve growth factor, a protein involved in the growth of nerve cells,...
    Gilead, insitro collaborates to discover, develop new therapies for Nonalcoholic Steatohepatitis

    Gilead, insitro collaborates to discover, develop new therapies for Nonalcoholic Steatohepatitis

    Garima20 April 2019 9:15 AM IST
    California: Gilead Sciences Inc. and insitro recently announced that the companies have entered into a strategic collaboration to discover and develop...
    USFDA outlines consideration on medical devices containing metal alloy nitinol

    USFDA outlines consideration on medical devices containing metal alloy nitinol

    Medical Dialogues Bureau20 April 2019 9:15 AM IST
    U.S: The U.S. Food and Drug Administration recently published a draft guidance titled, “Technical Considerations for Non-Clinical Assessment of...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Dr Lal PathLabs to acquire 70 percent stake in Amins Pathology Referral Laboratory

    Dr Lal PathLabs to acquire 70 percent stake in Amins Pathology Referral Laboratory

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok